BuzzRAG AI Desk — 2026-10-09

Nasdaq CEO Adena Friedman argues that blockchain-based tokenization could make institutional assets easier to mobilize, potentially freeing capital that is difficult to transfer or trade under existing arrangements. The claim is a view about the promise of the technology, not evidence in the supplied report that a specific volume of assets has already been unlocked.

Tokenization represents ownership or claims on assets as digital tokens, but the technical layer is only part of the job. Legal recognition, custody, settlement rules, liquidity and compatibility with existing financial systems determine whether those tokens can move beyond pilots. The comparison with AI is indirect but relevant to the day’s infrastructure theme: new computing systems often get attention for their capabilities, while adoption turns on governance and integration. The key test for the billions-scale proposition will be concrete deployments with transparent measures of cost, settlement speed and actual market participation.

Elon Musk has publicly criticized Indian business figure Mukesh Ambani as Starlink’s entry into India remains stalled amid a regulatory dispute described as lasting five years. The available report offers little detail about the specific rules or the latest decision, so the criticism should be read as one party’s intervention in a contested market, not a resolution of the dispute.

Satellite broadband depends on more than launching equipment: operators need permissions governing spectrum, security, service terms and market access. Those decisions can shape competition between satellite providers and established telecom networks, while affecting how quickly remote areas gain another connectivity option. The episode is not an AI development, but it illustrates a constraint shared across technology sectors: infrastructure ambitions are mediated by national policy and incumbent interests. What matters next is whether regulators clarify the requirements and whether the parties’ public argument produces a change in the approval process.

A new coding guide describes Google Research’s Regularized Recursive Self-Improvement (RRSI), presenting techniques including noise bands, cost rules and leakage screens for agents that iteratively revise their behavior. The item is a guide to an approach, not evidence in itself that an agent has achieved reliable or broadly capable self-improvement.

The proposed controls point to a central challenge in agent design: an iterative system can accumulate gains, but it can also exploit a flawed evaluator, spend resources without limit or leak information between tasks. Noise and cost constraints may help make experiments more robust and bounded; leakage checks address whether evaluation results are being improperly reused. The available snippet does not provide benchmark results, model sizes, or comparative performance, so it is not possible to judge how much RRSI improves agents over standard methods. The useful measure will be reproducible testing that reports both task gains and the failures the safeguards prevent.

Australian AI data-center operator Firmus has withdrawn its planned public offering, citing market volatility, according to the supplied report. The company is described as Nvidia-backed, but the snippet gives no offering size, revised timetable or detail on whether the withdrawal reflects company-specific factors alongside broader market conditions.

The decision highlights the capital intensity behind the AI boom. Data centers require large upfront commitments to land, power, cooling and specialized computing hardware, while revenue depends on sustained demand and utilization. A pulled IPO does not establish that demand for AI infrastructure is weakening; it does show that public-market conditions can complicate plans to raise money for expansion. Investors will be looking for signs of how Firmus intends to finance its buildout and whether other infrastructure operators face similar delays. For the sector, the important distinction is between appetite for AI services and willingness to fund projects at the valuations and timelines currently proposed.

A peer-reviewed Lancet study is reported to have evaluated Google’s AMIE medical AI in real clinical settings, bringing attention to evidence beyond a purely technical demonstration. The supplied summary says the system showed promise, but it does not identify the study design, patient count, clinical tasks, comparison group or measured outcomes. Those details are essential for interpreting what the results establish.

Clinical evaluation can test whether a model’s performance holds up amid incomplete information and the complexity of actual care, but a study does not by itself demonstrate readiness for routine deployment. The distinctions between assisting a clinician, matching expert judgments on selected tasks and improving patient outcomes matter. Peer review adds scrutiny, while study scope and independent replication determine how far the findings can travel. The next questions are how AMIE performed against clinicians and existing workflows, what limitations researchers reported, and whether later studies show reliable benefits across varied settings.